Ukrainian Journal Health of Woman. 2025. 5(180): 76-82. doi: 10.15574/HW.2025.5(180).7682
Bohadelnikova K. I.¹, Chaika K. V.¹, Tytarenko N. V.², Chaika V. V.¹, Bondaruk V. P.³, Mazur G. M.², Fedko Ye. V.^1
1Shupyk National Healthcare University of Ukraine, Kyiv
² National Pirogov Memorial Medical University, Vinnytsia, Ukraine
³Kyiv City Center for Reproductive and Perinatal Medicine, Ukraine

For citation: Bohadelnikova KI, Chaika KV, Tytarenko NV, Chaika VV, Bondaruk VP, Mazur GM, Fedko YeV. (2025). Modern strategies of conservative treatment of stress urinary incontinence in women. Ukrainian Journal Health of Woman. 5(180): 76-82. doi: 10.15574/HW.2025.5(180).7682
Article received: Jun 28, 2025. Accepted for publication: Oct 30, 2025.

The prevalence of stress urinary incontinence among non-pregnant women aged 20 years and older ranges from 27% to 64%. Various methods of conservative therapy are used as first-line treatment for urinary incontinence, including lifestyle and dietary modifications, pelvic floor muscle training, pharmacological therapy, electrical stimulation, the use of vaginal cones or urethral obturators.
Aim – to summarize current evidence on the effectiveness and safety of conservative methods for the treatment of stress urinary incontinence in women in order to form clinical competencies, promote patient-centered approaches, and ensure coordinated care among healthcare professionals.
Contemporary domestic and foreign research were identified and analyzed using available literary sources and electronic databases. This review evaluates current data on the effectiveness of various conservative treatment methods for stress urinary incontinence in women. Behavioral therapy and pelvic floor muscle training are recommended as primary first-line treatments. If these prove insufficient, the use of vaginal support devices, such as pessaries, may be considered as the next step in management. Notably, no pharmacological therapy has been approved by the U.S. Food and Drug Administration (FDA) specifically for SUI in women. Further controlled studies evaluating the long-term outcomes of various non-surgical treatment modalities (urethral bulking injections, laser and radiofrequency therapy, stem cell injections, etc.) are required.
Conclusions. The range of conservative treatment options for stress urinary incontinence is quite broad. When selecting a potential treatment method, its potential benefits and possible side effects affecting other aspects of a woman’s life should be taken into account.
No conflict of interest was declared by the authors.
Keywords: stress urinary incontinence, conservative therapy, lifestyle modification, pelvic floor muscle training, pharmacological therapy, electrical stimulation, vaginal cone, urethral obturator.
REFERENCES

1. Aguiar LB, Politano CA, Costa-Paiva L, Juliato CRT. (2020). Efficacy of Fractional CO2 Laser, Promestriene, and Vaginal Lubricant in the Treatment of Urinary Symptoms in Postmenopausal Women: A Randomized Clinical Trial. Lasers Surg Med. 52(8): 713-720. https://doi.org/10.1002/lsm.23220; PMid:31990089

2. Alexander JW, Karjalainen P, Ow LL, Kulkarni M, Lee JK, Karjalainen T et al. (2022). CO2 surgical laser for treatment of stress urinary incontinence in women: a randomized controlled trial. Am J Obstet Gynecol. 227(3): 473.e1-473.e12. https://doi.org/10.1016/j.ajog.2022.05.054; PMid:35662546

3. Alhasso A, Glazener CM, Pickard R, N'dow J. (2005). Adrenergic drugs for urinary incontinence in adults. Cochrane Database Syst Rev. 2005(3): CD001842. https://doi.org/10.1002/14651858.CD001842.pub2; PMid:16034867 PMCid:PMC8407415

4. Alsulihem A, Corcos J. (2021). The use of vaginal lasers in the treatment of urinary incontinence and overactive bladder, systematic review. Int Urogynecol J. 32(3): 553-572. https://doi.org/10.1007/s00192-020-04548-2; PMid:33175226

5. Arlandis S, Bø K, Cobussen-Boekhorst H, Costantini E, de Heide M, Farag F. (2022). European Association of Urology Guidelines on the Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 2: Underactive Bladder, Bladder Outlet Obstruction, and Nocturia. Eur Urol. 82(1): 60-70. https://doi.org/10.1016/j.eururo.2022.01.044; PMid:35181193

6. Berete F, Demarest S, Charafeddine R, De Ridder K, Vanoverloop J, Van Oyen H et al. (2022). Predictors of nursing home admission in the older population in Belgium: a longitudinal follow-up of health interview survey participants. BMC Geriatr. 22(1): 807. https://doi.org/10.1186/s12877-022-03496-4; PMid:36266620 PMCid:PMC9585772

7. Bø K, Kvarstein B, Nygaard I. (2005). Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years. Obstet Gynecol. 105; 5 Pt 1: 999-1005. https://doi.org/10.1097/01.AOG.0000157207.95680.6d; PMid:15863536

8. Brosche T, Kuhn A, Lobodasch K, Sokol ER. (2021). Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 40(1): 502-508. https://doi.org/10.1002/nau.24589; PMid:33410544 PMCid:PMC7839440

9. Castro-Diaz D, Robinsori D, Arlandis Guzman S, Bosch JLH, Costantini E, Cotterill N et al. (2023). Initial assessment of urinary incontinence in adult male and female patients. In: Cardozo L, Rovner E, Wagg A, Wein A, Abrams P, editors(s). INCONTINENCE. 7 edition. ICI-ICS: 398-436.

10. Chen J, Peng L, Xiang L, Li B, Shen H, Luo D. (2023). Association between body mass index, trunk and total body fat percentage with urinary incontinence in adult US population. Int Urogynecol J. 34(5): 1075-1082. https://doi.org/10.1007/s00192-022-05317-z; PMid:35960315

11. Chinthakanan O, Saraluck A, Kijmanawat A, Aimjirakul K, Wattanayingcharoenchai R, Manonai J. (2023). Comparison of Low-Energy Radiofrequency Thermal Vaginal Therapy with Sham Treatment for Stress Urinary Incontinence in Postmenopausal Women: A Randomized Controlled Trial. Int J Womens Health. 15: 1779-1790. https://doi.org/10.2147/IJWH.S431233; PMid:38020937 PMCid:PMC10657547

12. Christmas MM, Iyer S, Daisy C, Maristany S, Letko J, Hickey M. (2023). Menopause hormone therapy and urinary symptoms: a systematic review. Menopause. 30(6): 672-685. https://doi.org/10.1097/GME.0000000000002187; PMid:37192832

13. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. (2008). The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 101(11): 1388-1395. https://doi.org/10.1111/j.1464-410X.2008.07601.x; PMid:18454794

14. Dallosso HM, McGrother CW, Matthews RJ, Donaldson MM; Leicestershire MRC Incontinence Study Group. (2003). The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int. 92(1): 69-77. https://doi.org/10.1046/j.1464-410X.2003.04271.x; PMid:12823386

15. Dugan SA, Crawford SL, Wente K, Waetjen LE, Karvonen-Gutierrez C, Harlow SD. (2024). The association of urinary incontinence and disability among a diverse sample of midlife Study of Women's Health Across the Nation women. Menopause. 31(1): 18-25. https://doi.org/10.1097/GME.0000000000002282; PMid:38016162 PMCid:PMC10766380

16. Effective Health Care Program. (2012). Nonsurgical treatments for urinary incontinence in adult women: Diagnosis and comparative effectiveness. Agency for Healthcare Research Quality 2012. URL: https://effectivehealthcare.ahrq.gov/products/urinary-incontinence-treatment/research.

17. Eredics K, Wehrberger C, Edlinger L, Müller U, Rauchenwald M et al. (2023). Urinary Incontinence, Quality of Life, and Risk Factors in a Geriatric Cohort. Urol Int. 107(9): 866-871. https://doi.org/10.1159/000531582; PMid:37611548

18. Franić D, Fistonić I. (2019). Laser Therapy in the Treatment of Female Urinary Incontinence and Genitourinary Syndrome of Menopause: An Update. Biomed Res Int. 2019: 1576359. https://doi.org/10.1155/2019/1576359; PMid:31275962 PMCid:PMC6582847

19. Freitas AI, Isaksson C, Rahkola-Soisalo P, Mentula M, Mikkola TS. (2025). Tension-Free Vaginal Tape versus Polyacrylamide Hydrogel Injection for Stress Urinary Incontinence – 5-Year Follow-Up. NEJM Evid. 4(5): EVIDoa2400216. https://doi.org/10.1056/EVIDoa2400216; PMid:40261117

20. Goode PS, Burgio KL, Locher JL, Roth DL, Umlauf MG, Richter HE et al. (2003). Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: a randomized controlled trial. JAMA. 290(3): 345-352. https://doi.org/10.1001/jama.290.3.345; PMid:12865375

21. Güneş Y, Fersahoğlu MM, Bulut NE, Çakmak A, Ergin A, Teke E et al. (2023). Effects of Sleeve Gastrectomy on Pelvic Floor Disorders in Female Patients with Severe Obesity: a Prospective Study. Obes Surg. 33(10): 3069-3076. https://doi.org/10.1007/s11695-023-06725-w; PMid:37428362

22. Hampel C. (2023). Vaginal laser therapy-myths and facts. Urologie. 62(2): 132-140. https://doi.org/10.1007/s00120-022-02012-1; PMid:36625941

23. Hoe V, Haller B, Yao HH, O'Connell HE. (2021). Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic review. Neurourol Urodyn. 40(6): 1349-1388. https://doi.org/10.1002/nau.24696; PMid:34015151

24. Janssen CC, Lagro-Janssen AL, Felling AJ. (2001). The effects of physiotherapy for female urinary incontinence: individual compared with group treatment. BJU Int. 87(3): 201-6. https://doi.org/10.1046/j.1464-410x.2001.02040.x; PMid:11167642

25. Jonsson Funk M, Siddiqui NY, Kawasaki A, Wu JM. (2012). Long-term outcomes after stress urinary incontinence surgery. Obstet Gynecol. 120(1): 83-90. https://doi.org/10.1097/AOG.0b013e318258fbde; PMid:22914395 PMCid:PMC3508030

26. Kang D, Han J, Neuberger MM, Moy ML, Wallace SA et al. (2015). Transurethral radiofrequency collagen denaturation for the treatment of women with urinary incontinence. Cochrane Database Syst Rev. 2015(3): CD010217. https://doi.org/10.1002/14651858.CD010217.pub2

27. Lauterbach R, Aharoni S, Justman N, Farago N, Gruenwald I, Lowenstein L. (2022). The efficacy and safety of a single maintenance laser treatment for stress urinary incontinence: a double-blinded randomized controlled trial. Int Urogynecol J. 33(12): 3499-3504. https://doi.org/10.1007/s00192-022-05103-x; PMid:35195738 PMCid:PMC8864590

28. Le Berre M, Presse N, Morin M, Larouche M, Campeau L, Hu YX et al. (2020). What do we really know about the role of caffeine on urinary tract symptoms? A scoping review on caffeine consumption and lower urinary tract symptoms in adults. Neurourol Urodyn, 39(5): 1217-1233. https://doi.org/10.1002/nau.24344; PMid:32270903

29. Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L et al. (2017). Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial. JAMA. 317(24): 2493-2501. https://doi.org/10.1001/jama.2017.7220; PMid:28655016 PMCid:PMC5815072

30. Mackova K, Van Daele L, Page AS, Geraerts I, Krofta L, Deprest J. (2020). Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review. BJOG. 127(11): 1338-1346. https://doi.org/10.1111/1471-0528.16273; PMid:32333820

31. Okeahialam NA, Oldfield M, Stewart E, Bonfield C, Carboni C. (2022, Sep). Pelvic floor muscle training: a practical guide. British Medical Journal. BMJ. 327: 3070186. URL: https://www.bmj.com/content/378/bmj-2022-070186. https://doi.org/10.1136/bmj-2022-070186

32. Petca A, Fotă A, Petca RC, Rotar IC. (2025). Modern Conservative Management Strategies for Female Stress Urinary Incontinence: A Systematic Review. J Clin Med. 14(10): 3268. https://doi.org/10.3390/jcm14103268; PMid:40429264 PMCid:PMC12112232

33. Piernicka M, Labun J, Szumilewicz A. (2025). Training Interventions Used in Postmenopausal Women to Improve Pelvic Floor Muscle Function Related to Urinary Continence-A Systematic Review. J Clin Med. 14(13): 4800. https://doi.org/10.3390/jcm14134800; PMid:40649174 PMCid:PMC12251402

34. Qiao E, Burns H, Rodriguez MI, Cichowski SB. (2025). Urinary Incontinence and Menopausal Symptom Burden. Obstet Gynecol. 146(3): 402-404. https://doi.org/10.1097/AOG.0000000000005994; PMid:40609088

35. Rocha-Rangel SC, Pereira GMV, Juliato CRT, Brito LGO. (2025). Laser and Pelvic Floor Muscle Training for Urinary Incontinence: A Randomized Clinical Trial. Urogynecology (Phila). 31(6): 627-635. https://doi.org/10.1097/SPV.0000000000001516; PMid:38659104

36. Seki AS, Bianchi-Ferraro AMHM, Fonseca ESM, Sartori MGF, Girão MJBC, Jarmy-Di Bella ZIK. (2022). CO2 Laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3). A randomized controlled trial. Int Urogynecol J. 33(12): 3535-3542. https://doi.org/10.1007/s00192-022-05091-y; PMid:35254473

37. Shamliyan TA, Kane RL, Wyman J, Wilt TJ. (2008, Mar 18). Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med. 148(6): 459-473. https://doi.org/10.7326/0003-4819-148-6-200803180-00211; PMid:18268288

38. Sun K, Zhang D, Wu G, Wang T, Wu J et al. (2021). Efficacy of magnetic stimulation for female stress urinary incontinence: a meta-analysis. Ther Adv Urol. 13: 17562872211032485. https://doi.org/10.1177/17562872211032485; PMid:34345251 PMCid:PMC8283222

39. Taastrøm K, Kjeldsen AC, Hjorth S, Gommesen D, Axelsen SM, Nohr EA. (2024). Urinary Incontinence in Midlife According to Weight Changes Across and After Childbearing Years. Int Urogynecol J. 35(3): 579-588. https://doi.org/10.1007/s00192-023-05713-z; PMid:38214717 PMCid:PMC11024002

40. Todhunter-Brown A, Hazelton C, Campbell P, Elders A, Hagen S, McClurg D. (2022). Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 9(9): CD012337. https://doi.org/10.1002/14651858.CD012337.pub2; PMid:36053030 PMCid:PMC9437962

41. Wang Y, Wang C, Song F, Zhou Y, Wang Y. (2021). Safety and efficacy of vaginal laser therapy for stress urinary incontinence: a meta-analysis. Ann Palliat Med. 10(3): 2736-2746. https://doi.org/10.21037/apm-20-1440; PMid:33549008

42. Winkler H, Jacoby K, Kalota S, Snyder J, Cline K, Robertson K et al. (2018). Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon. Female Pelvic Med Reconstr Surg. 24(3): 222-231. https://doi.org/10.1097/SPV.0000000000000488; PMid:28953076 PMCid:PMC5943078

43. Wu JM. (2021). Stress Incontinence in Women. N Engl J Med. 384(25): 2428-2436. https://doi.org/10.1056/NEJMcp1914037; PMid:34161707

44. Yang X, Wang X, Gao Z, Li L, Lin H, Wang H et al. (2022). The Anatomical Pathogenesis of Stress Urinary Incontinence in Women. Medicina (Kaunas). 59(1): 5. https://doi.org/10.3390/medicina59010005; PMid:36676629 PMCid:PMC9865065